Drug For Mutiple Sclerosis Recommended For FDA Approcal
The FDA is expected to grant approval for COPAXONE, a protein-like molecule that reduces multiple sclerosis attacks and produces minimal side effects. The drug was developed by Teva Pharmaceutical Industries Ltd. and shows promise in treating relapsing-remitting multiple sclerosis.